APLS and Sobi Collaboration for Global Co-development and Ex-US Commercialization of Systemic Pegcetacoplan in Rare Diseases with Urgent Need for New Treatments.
$APLS to receive $250M upfront.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.